Authors: MANDICH P JACOPINI G DIMARIA E SABBADINI G ABBRUZZESE G CHIMIRRI F BELLONE E NOVELLETTO A AJMAR F FRONTALI M

Citation: P. Mandich et al., PREDICTIVE TESTING FOR HUNTINGTONS-DISEASE - 10 YEARS EXPERIENCE IN 2ITALIAN CENTERS (VOL 19, PG 68, 1998), Italian journal of neurological sciences, 19(3), 1998, pp. 149-149

Authors: MANDICH P JACOPINI G DIMARIA E SABBADINI G CHIMIRRI F BELLONE E NOVELLETTO A AJMAR F FRONTALI M

Citation: P. Mandich et al., PREDICTIVE TESTING FOR HUNTINGTONS-DISEASE - 10 YEARS EXPERIENCE IN 2ITALIAN CENTERS, Italian journal of neurological sciences, 19(2), 1998, pp. 68-74

Authors: CARELLA AM CUNNINGHAM I LERMA E DEJANA A BENVENUTO F PODESTA M CELESTI L CHIMIRRI F ABATE M VASSALLO F FIGARI O PARODI C SESSAREGO M VALBONESI M CARLIER P PRENCIPE E GATTI AM VANDENBERG D HOFFMAN R FRASSONI F

Citation: Am. Carella et al., MOBILIZATION AND TRANSPLANTATION OF PHILADELPHIA-NEGATIVE PERIPHERAL-BLOOD PROGENITOR CELLS EARLY IN CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 15(4), 1997, pp. 1575-1582

Authors: CARELLA AM PODESTA M LERMA E DEJANA A PRENCIPE E VASSALLO F CRESCENTI C SORACCO M BENVENUTO F CHIMIRRI F CARLIER P FLORIO G VALBONESI M FRASSONI F

Citation: Am. Carella et al., MOBILIZATION TRANSPLANTATION OF PH(1)-NEGATIVE BLOOD PROGENITOR CELLSIN CHRONIC MYELOGENOUS LEUKEMIA/, Annals of oncology, 7, 1996, pp. 19-22

Authors: CARELLA AM CHIMIRRI F PODESTA M PITTO A PIAGGIO G DEJANA A LERMA E POLLICARDO N VASSALLO F SORACCO M BENVENUTO F VALBONESI M CARLIER P VIMERCATI R PRENCIPE E GATTI AM FERRARA RA INCAGLIATO M FLORIO G FRASSONI F

Citation: Am. Carella et al., HIGH-DOSE CHEMORADIOTHERAPY FOLLOWED BY AUTOLOGOUS PHILADELPHIA CHROMOSOME-NEGATIVE BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 17(2), 1996, pp. 201-205

Authors: CARELLA AM DEJANA A LERMA E PODESTA H BENVENUTO F CHIMIRRI F PARODI C SESSAREGO M PRENCIPE E FRASSONI F

Citation: Am. Carella et al., IN-VIVO MOBILIZATION OF KARYOTYPICALLY NORMAL PERIPHERAL-BLOOD PROGENITOR CELLS IN HIGH-RISK MDS, SECONDARY OR THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA, British Journal of Haematology, 95(1), 1996, pp. 127-130